Rockwell Medical (RMTI) Tops Q4 EPS by 4c ; Offers Guidance
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $0.68 +6.25%
EPS Growth %: -200.0%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
OCCI, MAYS, CRMT, More
EPS Growth %: -200.0%
Financial Fact:
Research and Product Development: 1.26M
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q4 EPS of $0.04, $0.04 better than the analyst estimate of $0.00. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.07 million.
GUIDANCE:
Rockwell Medical sees FY2025 revenue of $65-70 million, versus the consensus of $83.19 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Incyte (INCY) PT Raised to $105 at Truist Securities
- Texas AG Paxton announces ongoing investigation into Carnival over data breach
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
